Turning tumors from cold to inflamed to improve immunotherapy response von Gerard, C.L., Delyon, J., Wicky, A., Homicsko, K., Cuendet, Michel A., Michielin, O.

Volltext

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy von Ghisoni, E., Wicky, A., Bouchaab, H., Imbimbo, M., Delyon, J., Gautron Moura, B., Gérard, C.L., Latifyan, S., Özdemir, B.C., Caikovski, M., Pradervand, S., Tavazzi, E., Gatta, R., Marandino, L., Valabrega, G., Aglietta, M., Obeid, M., Homicsko, K., Mederos Alfonso, N.N., Zimmermann, S., Coukos, G., Peters, S., Cuendet, M.A., Di Maio, M., Michielin, O.

Volltext

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma von Gavrielatou, N., Fortis, E., Spathis, A., Anastasiou, M., Economopoulou, P., Foukas, G.R.P., Lelegiannis, I.M., Rusakiewicz, S., Vathiotis, I., Aung, T.N., Tissot, S., Kastrinou, A., Kotsantis, I., Vagia, E.M., Panayiotides, I., Rimm, D.L., Coukos, G., Homicsko, K., Foukas, P., Psyrri, A.

Volltext

3356 Triple wild type melanoma profiling in the Caris Molecular IntelligenceTM registry von Homicsko, K, Kenneth, R, Voss, A, Michielin, O

Volltext

Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches von Digklia, A., Duran, R., Homicsko, K., Kandalaft, L. E., Hocquelet, A., Orcurto, A., Coukos, G., Denys, A.

Volltext

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors von Stathis, A., Hess, D., von Moos, R., Homicsko, K., Griguolo, G., Joerger, M., Mark, M., Ackermann, C. J., Allegrini, S., Catapano, C. V., Xyrafas, A., Enoiu, M., Berardi, S., Gargiulo, P., Sessa, C.

Volltext

Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients von Homicsko, K., Richtig, G., Tuchmann, F., Tsourti, Z., Hanahan, D., Coukos, G., Wind-Rotolo, M., Richtig, E., Zygoura, P., Holler, C., Dafni, U., Michielin, O.A.

Volltext

Compact solid-state CMOS single-photon detector array for in vivo NIR fluorescence lifetime oncology measurements von Homulle, H A R, Powolny, F, Stegehuis, P L, Dijkstra, J, Li, D-U, Homicsko, K, Rimoldi, D, Muehlethaler, K, Prior, J O, Sinisi, R, Dubikovskaya, E, Charbon, E, Bruschini, C

Volltext

2278P Endothelial cell heterogeneity defined by single-cell spatial transcriptomic analysis of breast cancers von Homicsko, K., Zaman, K., Stravodimou, A.

Volltext

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC) von O’Cearbhaill, R.E., Wolfer, A., Disilvestro, P., O’Malley, D.M., Sabbatini, P., Shohara, L., Schwarzenberger, P.O., Ricciardi, T., Macri, M., Ryan, A., Venhaus, R.R., Bryan, J.K., Wong, P., Homicsko, K., Kandalaft, L., Rusakiewicz, S., Harari, A., Monk, B.J., Coukos, G.

Volltext

Decision making and management of gliomas: practical considerations von Hottinger, A F, Homicsko, K, Negretti, L, Lhermitte, B, Stupp, R

Volltext

340 A phase I study of the smoothened (SMO) antagonist LDE225 in combination with paclitaxel in patients with advanced solid tumors von Stathis, A, Hess, D, Xyrafas, A, Enoiu, M, Berardi, S, Moos, R. Von, Homicsko, K, Griguolo, G, Jörger, M, Mark, M, Ackermann, C, Sessa, C

Volltext

505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine von Tabernero, J, Homicsko, K, Schellens, J.H, Hoekstra, O, Van der Veen, L, Melero, I, és, G. Argil, Mau-Sorensen, M, Angevin, E, Joensuu, H, Van Brummelen, E, van Oordt, C.W. Menke-van der Houven, Nayak, T, Romagnoli, S, Reis, B, Brossard, S. Soehrman, Evers, S, Saro, J, Verheul, H, Lassen, U

Volltext

617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study von Simonelli, M., Lorusso, D., Homicsko, K., Seguy, F., Kinder, M., Liu, Q., Croft, E., Kitano, S.

Volltext

28INNEW MOLECULAR CLASSIFICATION OF COLORECTAL CANCER von Homicsko, K., Sadanandam, A.

Volltext

New Molecular Classification of Colorectal Cancer von Homicsko, K., Sadanandam, A.

Volltext

Original Research Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy von Ghisoni, E., Wicky, A., Bouchaab, H., Imbimbo, M., Delyon, J., Moura, B. Gautron, Gerard, C. L., Latifyan, S., Ozdemir, B. C., Caikovski, M., Pradervand, S., Tavazzi, E., Gatta, R., Marandino, L., Valabrega, G., Aglietta, M., Obeid, M., Homicsko, K., Alfonso, N. N. Mederos, Zimmermann, S., Coukos, G., Peters, S., Cuendet, M. A., Di Maio, M., Michielin, O.

Volltext

4OTumour cells mirror embryonic developmental programs to acquire invasive and metastatic capabilities von Saghafinia, S, Michael, I, Homicsko, K, Hanahan, D

Volltext

Tumour cells mirror embryonic developmental programs to acquire invasive and metastatic capabilities von Saghafinia, S., Michael, I., Homicsko, K., Hanahan, D.

Volltext

Comparison of Molecular Strategies for Breast Cancer Virotherapy Using Oncolytic Adenovirus von BAZAN-PEREGRINO, M, CARLISLE, R. C, HERNANDEZ-ALCOCEBA, R, IGGO, R, HOMICSKO, K, FISHER, K. D, HALLDEN, G, MAUTNER, V, SHEN, Y, SEYMOUR, L. W

Volltext